Use of defibrotide and at least one haematopoietic factor to...

Details Use of defibrotide and at least one haematopoietic factor to... Use of defibrotide and at least one haematopoietic factor to...

A - Human Necessities

61

K

A61K 38/19 (2006.01) C12N 5/078 (2010.01) A61K 31/70 (2006.01) A61K 31/711 (2006.01) A61P 7/00 (2006.01)

Patent

CA 2406179

A description is given of a method of increasing the amount of stem cells and progenitor cells in the peripheral blood of a mammal; the method is characterised by the administration of defibrotide in combination or in temporal proximity with at least one haematopoietic factor, (preferably G-CSF) having the capacity to mobilise haematopoietic progenitors.

L'invention concerne un procédé pour augmenter la quantité de cellules embryonnaires et de cellules souches dans le sang périphérique d'un mammifère. Ce procédé se caractérise par l'administration de défibrotide rapprochée dans le temps ou combinée à au moins un facteur hématopoïétique (de préférence G-CSF) ayant la faculté de mobiliser des précurseurs hématopoïétiques.

Affiliated with

Also associated with

Rating

Use of defibrotide and at least one haematopoietic factor to... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of defibrotide and at least one haematopoietic factor to..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of defibrotide and at least one haematopoietic factor to... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1805219